Nikkei Biotechnology

Nikkei Biotechnology channel feed

'Op­ti­miz­ing R&D struc­ture is al­so on the hori­zon, with­out ex­cep­tion,' new Sum­it­o­mo Phar­ma CEO says

10 months ago
Pharma

Sum­it­o­mo and Japan Na­tion­al In­sti­tute's uni­ver­sal in­fluen­za vac­cine en­ters clin­i­cal tri­als

12 months ago

Shi­madzu Cor­po­ra­tion es­tab­lish­es three R&D cen­ters in the US in an­tic­i­pa­tion of busi­ness ex­pan­sion for phar­ma­ceu­ti­cal com­pa­nies

Last year
Manufacturing

GNI Group to form $100M fund with Chi­nese state-owned en­ter­pris­es

Last year
China

Japan­ese phar­ma­ceu­ti­cal reg­u­la­tions un­der re­view to re­solve drug short­ages and en­sure sta­ble sup­ply

Last year

Mei­ji Sei­ka Phar­ma to sup­ply Japan with self-am­pli­fy­ing mR­NA Covid-19 vac­cine in fall/win­ter of 2024

Last year
A service from the Financial Times